CH

China Traditional Chinese Medicine Holdings Co LtdOOTC CHIZF Stock Report

Last reporting period 31 Dec, 2023

Updated 30 Oct, 2024

Last price

Market cap $B

0.03

Micro

Exchange

OOTC - OTC

CHIZF Stock Analysis

CH

Uncovered

China Traditional Chinese Medicine Holdings Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

40/100

Low score

Market cap $B

0.03

Dividend yield

3.30 %

Shares outstanding

5 035.8 B

China Traditional Chinese Medicine Holdings Co., Ltd. operates as an investment holding company, which engages in the research and development, production and sale of Chinese medicine and pharmaceutical products. The company employs 17,361 full-time employees The firm operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.

View Section: Eyestock Rating